Huizinga Robert Bindert
EVP of Research at AUPH
- Sold, on record
- $5.5M
- Dollars the filings state
- Form 4 sales
- 5
- Latest Mar 2, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- AUPHAurinia Pharmaceuticals Inc.EVP of Research
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale AUPHPlan not statedSep 7, 2021 2021
Sold 5,000 shares at $18.30 ($92k)
Huizinga Robert Bindert, EVP of Research
Sold 3.5% of holdings ($2.6M position)138,592 shares leftFirst sale on recordFiling
- 2 Form 4 sale AUPHPlan not statedSep 14, 2021 +7 days
Sold 32,500 shares at $21.15 ($687k)
Huizinga Robert Bindert, EVP of Research
Sold 23.5% of holdings ($2.9M position)106,092 shares leftFiling
- 3 Form 4 sale AUPHPlan not statedSep 21, 2021 +7 days
Sold 32,500 shares at $23.99 ($780k)
Huizinga Robert Bindert, EVP of Research
Sold 24.4% of holdings ($3.2M position)100,728 shares leftFiling
- 4 Form 4 sale AUPHUnusualOct 25, 2021 +34 days
Sold 130,000 shares at $29.75 ($3.9M)
Huizinga Robert Bindert, EVP of Research
Sold 66.4% of holdings ($5.8M position)65,728 shares left4x usual sizeFiling
- 5 Form 4 sale AUPHPlan not statedMar 2, 2022 +128 days
Sold 4,849 shares at $12.01 ($58k)
Huizinga Robert Bindert, EVP of Research
Sold 6.5% of holdings ($891k position)69,379 shares left0.1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2022 | Mar 4, 2022 | AUPH | EVP of Research | Form 4 sale | 4,849 | $58k | 6.5% | Plan not stated | SEC |
| Oct 25, 2021 | Oct 26, 2021 | AUPH | EVP of Research | Form 4 sale | 130,000 | $3.9M | 66.4% | Unusual | SEC |
| Sep 21, 2021 | Sep 22, 2021 | AUPH | EVP of Research | Form 4 sale | 32,500 | $780k | 24.4% | Plan not stated | SEC |
| Sep 14, 2021 | Sep 14, 2021 | AUPH | EVP of Research | Form 4 sale | 32,500 | $687k | 23.5% | Plan not stated | SEC |
| Sep 7, 2021 | Sep 8, 2021 | AUPH | EVP of Research | Form 4 sale | 5,000 | $92k | 3.5% | Plan not stated | SEC |